CEO and founder of ARCpoint Labs, Felix Mirando, was recently featured in Upstate Business Journal. In the article titled “Franchise, diversify, expand — repeat,” Mirando highlights the competitive advantages and consumer benefits that set ARCpoint Labs apart from other drug testing companies, particularly the growth and diversification of the brand.
Since its inception as a franchise in 2005, ARCpoint Labs has grown from 5 owners to 78 owners and almost 100 locations nationwide. Far from just a drug testing solution, ARCpoint Labs offers innovative clinical health services, including the recently-launched ARCpoint MD telehealth services and cutting edge DNA testing — pharmacogenetics — that determines the most safe and efficacious prescription drugs for individual patients. ARCpoint Labs is evolving to provide tailored, convenient treatment for the modern world.
Notable figures from the article include our projected growth, an estimated 15 to 20 new owners and 30 to 35 new territories annually with 275 locations by 2020.